Rare diseases
Investigational molecules
Locations
Study on the Safety of GEN1053 Alone and with an Immunomodulator for Patients with Malignant Solid Tumors
SpainStudy for Patients with Advanced Malignancies: Continued Treatment with Parsaclisib Alone or with Itacitinib, Ruxolitinib, Ibrutinib, or Tafasitamab
SpainStudy of EQU-001 and Placebo for Patients with Uncontrolled Focal Seizures in Epilepsy
SpainStudy of Telisotuzumab Vedotin for Adults with Advanced Non-Squamous Non-Small Cell Lung Cancer
SpainLong-Term Safety Study of HepaStem for Patients with Urea Cycle Disorders, Crigler-Najjar Syndrome, and Fibroinflammatory Liver Diseases
SpainStudy of Pembrolizumab for Patients with Advanced Solid Tumors
SpainStudy on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia
SpainStudy on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell Lung Cancer in Patients After Platinum Chemotherapy and Immunotherapy
SpainStudy on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Richter Transformation (RT)
SpainStudy on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Waldenstrom Macroglobulinemia Using a Drug Combination
SpainStudy on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis
SpainStudy of Pembrolizumab and Chemotherapy for Patients with Triple Negative Breast Cancer
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
